MILAN , March 10, 2022 /PRNewswire/ -- Dedalus Group ("Dedalus"), the leading healthcare and diagnostic software solutions provider in Europe , and Ibex Medical Analytics ("Ibex"), the market leader in artificial intelligence (AI)-powered cancer diagnostics, today announced a strategic partnership to bring the power of artificial intelligence to digital pathology.
The partnership will bring the power of Ibex's clinical-grade AI algorithms into Dedalus' end-to-end digital pathology solution. This will benefit pathologists and patients through enhanced quality of diagnosis, at speed.
The increasing demand for pathology services posed by the growing number of cancer patients and global shortage of trained pathologists, leads pathology laboratories to actively seek efficiency-enhancing solutions that enable them to maintain high accuracy levels and reduce time to diagnosis.
Dedalus' end-to-end digital pathology solution addresses the needs of anatomic pathology labs and ensures interoperability with existing multi-vendor solutions, enabling a seamless, gradual evolution towards full digitization to meet the increasing demands of the healthcare system.
With over 30 years' experience in laboratory solutions, Dedalus has deployments in over 5700 laboratories globally, and has been instrumental in successfully bringing cutting-edge technologies into the laboratories to make the systems as agile, efficient, and accurate as possible.
Ibex transforms cancer diagnosis by harnessing AI and machine learning technologies at an unprecedented scale. The company's Galen™ platform has demonstrated outstanding outcomes in multiple clinical studies on various tissue types and clinical workflows. It is deployed in labs worldwide where it is used as part of everyday clinical practice.
Ibex's clinical-grade AI algorithms will seamlessly integrate into Dedalus end-to end digital pathology solution, enabling smooth workflows from a single application. The joint solution will analyse cases prior to human pathologists' review, providing decision support tools that will enable increased focus on cancerous slides and areas of interest, streamline reporting, improve laboratory efficiency, and increase diagnostic confidence.
"Dedalus is the leading healthcare and diagnostic software provider in Europe . As part of our commitment to accelerate the digital transformation in healthcare, we strongly believe in the value of artificial intelligence, specifically in pathology and cancer diagnoses. Therefore, we are proud to partner with Ibex Medical Analytics, which is a global leader in AI-powered solutions for pathology labs and cancer diagnostics," said Marlen Suller , Head of In Vitro Diagnostics Business Unit at Dedalus.
"Our AI solutions transform pathology and help physicians around the world provide on-time, quality diagnosis to patients," said Joseph Mossel , CEO and Co-founder of Ibex Medical Analytics. "Yet to unlock the full potential of artificial intelligence, pathologists and health systems need AI-enabled workflows and integrated cancer pathways. We are excited to partner with market leaders Dedalus and to deliver end-to-end diagnostic modalities that improve the way laboratories work and support better cancer care."
Dedalus Group is the leading healthcare and diagnostic software provider in Europe , supporting the digital transformation of 6300 hospitals and 5700 Laboratories worldwide, processing its solutions for more than 540 millions of population worldwide. Dedalus supports the whole continuum of care, offering open standards-based solutions serving each actor of the Healthcare Ecosystem to provide better care in a healthier planet.
For more information, visit www.dedalus.com
Ibex pioneers AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis by developing clinical-grade AI algorithms and digital workflows that help detect and grade cancer in biopsies. Our Galen™ platform is the first-ever AI-powered integrated diagnostics solution in pathology and used in routine clinical practice worldwide, supporting pathologists and providers in improving the quality and accuracy of diagnosis, implementing comprehensive quality control, reducing turnaround times and boosting productivity with more efficient workflows.
For more information, visit www.ibex-ai.com
DEDALUS SPA Press Contact: Sara Luisa Mintrone Tel number +39 348 2818185 sara.mintrone@dedalus.eu
Ibex Medical Analytics Press contact: Eitan Goldstein Tel number +972 54 3331909 eitan@gkpr.com
For further information: www.dedalus.com LinkedIn :Dedalus group
For further information: www.ibex-ai.com LinkedIn:Ibex
View original content:https://www.prnewswire.com/news-releases/dedalus-and-ibex-announce-a-strategic-partnership-to-bring-the-power-of-artificial-intelligence-to-digital-pathology-301499889.html
SOURCE Ibex Medical Analytics; Dedalus Group
Investors know that the key to profits is in the return – and that means, a willingness to shoulder risk. Risk is relative, of course, and tends to run hand-in-hand with the return potential. Find a stock with a giant return potential, and chances are, you’ve also found one with a higher risk profile. The highest returns usually come along with the lowest share prices. After all, when a stock is priced for just pennies, even a small gain in share price translates into a huge return. Which means
The biotech stock is making gains despite market pressures, but it's still down roughly 71% from its high.
It turns out that extra hour of sleep is more important than you may think.
Since the beginning of February, Sandrock has joined the boards of directors of four biotech startups, most recently Boston-based central nervous system company Atalanta Therapeutics.
A new coronavirus variant, deltacron, is a mix between delta and omicron. It has been found in at least 17 patients in the U.S. and Europe, the World Health Organization says.
David Bennett, the Maryland man who was the first person to ever receive a genetically modified pig’s heart, died Tuesday afternoon two months after receiving the landmark transplant. No obvious cause of death was identified at the time, according to reports, and the University of Maryland Medical Center in Baltimore said Wednesday that Bennett’s condition began deteriorating “several days ago” and it “became clear that he would not recover.” Bennett, 57, had terminal heart disease and was deemed ineligible for a conventional heart transplant, which led him to take on the experimental operation.
Nina Dobrev just showed off her ultra-toned legs and abs in a white bikini photo on Instagram. To stay fit, Nina does a mix of boxing, running, and yoga.
Patients who take prescribed medicines depend on the label for accuracy. But in some cases, the label may not exactly match the contents of the drugs inside—and that can be a serious problem. Read on to find out about the latest drug recall resulting from multiple medications that don't meet specifications—and learn what to do if you have any of the affected drugs at home right now.RELATED: This Medication Is Being Recalled Effective Immediately, FDA Warns. Olympia Pharmacy is voluntarily recall
You might lose some sleep, but there are warmer, sunnier days ahead
Incannex Healthcare Limited (NASDAQ: IXHL) has completed a preliminary analysis of data from its Phase 2 trial of a cannabinoid combination product, IHL-42X, for obstructive sleep apnoea (OSA). The clinical trial assessed three doses of IHL-42X at reducing the apnoea hypopnoea index (AHI), the main diagnostic and monitoring criteria for OSA, compared to placebo. For all IHL-42X treatment periods (using low, mid, and high doses), the average AHI was 23.81, a 44.4 % reduction from the baseline sco
Stress related to money hit its highest level since 2015, the American Psychological Association says.
Newborn Veronika curled against her mother’s side on Friday, as if to hide from the horror around them — the war that tore apart the Mariupol maternity hospital where she was meant to greet the world. On the eve of giving birth, her mother, Mariana Vishegirskaya, had to flee the hospital when a Russian airstrike hit. Images of the desperate mothers and medical workers from the Children's and Women's Health hospital shocked the world, as the bombing took Russia’s war against Ukraine to a sickening new level.
Fitness model and IFBB Figure pro Felicia Romero offers her best tips to get the most out of every sweat session.
'Dancing With the Stars' judge Carrie Ann Inaba shares health news with fans after leaving the CBS show 'The Talk' last year.
Brussels is putting its pigeon population on the contraceptive pill to solve the city’s growing pest problem.
Two years ago, the World Health Organization declared COVID-19 a pandemic. Dr. Celine Gounder, an infectious disease specialist at NYU and Bellevue Hospital, host of the podcast "Epidemic" and editor at large for public health at Kaiser Health News, spoke with CBS News about how far the world has come in the fight against the coronavirus and what comes next.
“The fact that we still have congenital syphilis is one of the great public health failures of our time.”
Ukrainian authorities have said three people, including a child, died when the hospital in the southern city of Mariupol was bombed on Wednesday.
Two years into the COVID-19 pandemic, most of the world has seen a dramatic improvement in infections, hospitalizations and death rates in recent weeks, signaling the crisis appears to be winding down. Past epidemics may provide clues. The ends of epidemics are not as thoroughly researched as their beginnings.
"At the end of the day, 'I don’t want to have kids' is reason enough and should be respected."View Entire Post ›